Market Cap 971.08M
Revenue (ttm) 16.10M
Net Income (ttm) -198.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,235.84%
Debt to Equity Ratio 0.25
Volume 1,617,300
Avg Vol 3,640,558
Day's Range N/A - N/A
Shares Out 62.53M
Stochastic %K 65%
Beta 0.73
Analysts Strong Sell
Price Target $38.55

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
ProgressiveSystem
ProgressiveSystem Mar. 18 at 6:49 AM
$QURE is on my radar in biotech, just observing.
0 · Reply
stu4
stu4 Mar. 18 at 1:48 AM
$QURE because of the CEO MATT !!! Said it all along Ex stock broker , not a CEO
0 · Reply
EarthRocketTraders
EarthRocketTraders Mar. 17 at 11:58 PM
0 · Reply
Peterson28
Peterson28 Mar. 17 at 7:40 PM
$QURE Who the dumb bought the massive $30 calls expiring this Friday?
0 · Reply
janed102
janed102 Mar. 17 at 5:45 PM
$QURE company would be worth more if it delisted from the US stock market
0 · Reply
pk81
pk81 Mar. 17 at 2:08 PM
0 · Reply
verusabiz
verusabiz Mar. 16 at 7:36 PM
$QURE what a pos this has turned out to be, no one wants to own it
0 · Reply
calidave123
calidave123 Mar. 16 at 9:18 AM
0 · Reply
Th3M4skedSt0nker
Th3M4skedSt0nker Mar. 16 at 3:01 AM
$KYTX is an easy 100%-200% this year alone. Might happen actually very fast within next 3 months with the given catalyst pipeline. Strong institutional ownership. Strong insider confidence with recent market buys. Only retail is still sleeping on this beauty...compare no. of watchers to $SLS $CING $QURE Good Luck Dear Ladies and Gentlemen 💲 💲💲
1 · Reply
MichaelReis
MichaelReis Mar. 15 at 10:38 PM
0 · Reply
Latest News on QURE
uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript

Mar 2, 2026, 4:27 PM EST - 15 days ago

uniQure N.V. (QURE) Q4 2025 Earnings Call Transcript


uniQure to Announce 2025 Financial Results

Feb 23, 2026, 7:05 AM EST - 22 days ago

uniQure to Announce 2025 Financial Results


Alger Small Cap Focus Fund Q4 2025 Portfolio Update

Jan 29, 2026, 1:22 PM EST - 6 weeks ago

Alger Small Cap Focus Fund Q4 2025 Portfolio Update

EXAS GH NBIS NTRA STVN


uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 2 months ago

uniQure Announces Type A Meeting Scheduled with FDA


uniQure: Now What?

Jan 8, 2026, 3:36 PM EST - 2 months ago

uniQure: Now What?


What's Going On With uniQure Stock On Tuesday?

Dec 16, 2025, 12:17 PM EST - 3 months ago

What's Going On With uniQure Stock On Tuesday?


Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 1:30 PM EST - 3 months ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update


uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 11:11 AM EST - 4 months ago

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript


uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 4 months ago

uniQure to Announce Third Quarter 2025 Financial Results


ProgressiveSystem
ProgressiveSystem Mar. 18 at 6:49 AM
$QURE is on my radar in biotech, just observing.
0 · Reply
stu4
stu4 Mar. 18 at 1:48 AM
$QURE because of the CEO MATT !!! Said it all along Ex stock broker , not a CEO
0 · Reply
EarthRocketTraders
EarthRocketTraders Mar. 17 at 11:58 PM
0 · Reply
Peterson28
Peterson28 Mar. 17 at 7:40 PM
$QURE Who the dumb bought the massive $30 calls expiring this Friday?
0 · Reply
janed102
janed102 Mar. 17 at 5:45 PM
$QURE company would be worth more if it delisted from the US stock market
0 · Reply
pk81
pk81 Mar. 17 at 2:08 PM
0 · Reply
verusabiz
verusabiz Mar. 16 at 7:36 PM
$QURE what a pos this has turned out to be, no one wants to own it
0 · Reply
calidave123
calidave123 Mar. 16 at 9:18 AM
0 · Reply
Th3M4skedSt0nker
Th3M4skedSt0nker Mar. 16 at 3:01 AM
$KYTX is an easy 100%-200% this year alone. Might happen actually very fast within next 3 months with the given catalyst pipeline. Strong institutional ownership. Strong insider confidence with recent market buys. Only retail is still sleeping on this beauty...compare no. of watchers to $SLS $CING $QURE Good Luck Dear Ladies and Gentlemen 💲 💲💲
1 · Reply
MichaelReis
MichaelReis Mar. 15 at 10:38 PM
0 · Reply
InvestorNOR
InvestorNOR Mar. 15 at 4:00 PM
$QURE Next domino to fall will be Makary after hearing with Senator Ron Johnson. Trump will approve AMT-130 soon. I can feel it in my bones!
1 · Reply
stu4
stu4 Mar. 14 at 8:26 PM
$QURE LOSER …everyone knows your handle
0 · Reply
jewell69
jewell69 Mar. 13 at 6:54 PM
$QURE 2 hot 2 handle
1 · Reply
verusabiz
verusabiz Mar. 13 at 4:43 PM
$QURE why:
0 · Reply
Teillbou
Teillbou Mar. 13 at 4:22 PM
$QURE no volume, no stress
0 · Reply
Cutlass
Cutlass Mar. 13 at 4:01 PM
$QURE QURE ALERT: FDA Reportedly Accuses uniQure of Pushing “Distorted” and “Manipulated” Data For “Failed” AMT-130 Drug GLOBENEWSWIRE 10:59 AM ET 3/13/2026
2 · Reply
truehealthvalue
truehealthvalue Mar. 12 at 9:29 PM
$QURE take a look at $ELTX CEO comment 30’ ago: “Fewer disease progressions and deaths than projected to date have been observed in the ongoing 2:1 randomized Phase 2 AMPLIFY-7P trial” The previous comment by Elicios CEO is key: he is telling you that the results are guaranteed to be good, better than anything currently available. This company could be one of the best investments in the history of biotechnology. It is certainly worth much more than its current valuation. I will Increase my position
1 · Reply
verusabiz
verusabiz Mar. 12 at 8:22 PM
$QURE not worried about lawsuits, lawyers can keep this in court for years and then the company just declares bankruptcy
0 · Reply
CulinaryCapitalist
CulinaryCapitalist Mar. 12 at 7:48 PM
$QURE https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qure/uniqure/news/uniqure-faces-amt-130-scrutiny-as-fda-shifts-and-lawsuits-we
0 · Reply
11thestate
11thestate Mar. 12 at 6:37 PM
As we were exploring $QURE , we came across this. (And it's the kind of thing you're not prepared to see): https://11th.com/cases/uniqure-investor-suit
0 · Reply
CulinaryCapitalist
CulinaryCapitalist Mar. 12 at 1:44 PM
0 · Reply
mv21970
mv21970 Mar. 12 at 12:38 PM
$BHVN great article about how the FDA is denying much needed medications and destroying the development of rare disease drugs: https://www.biospace.com/fda/opinion-rare-disease-patients-cant-wait-for-regulatory-process After reading this and remembering what Makary recently said on CNBC about faster approvals and flexibility blabla, he should be fired immediately for lying to the public. I guess both guys are proud and calling themselves genius when patients die and they deny them the only possible therapy, f*ing morons $CAPR $RGNX $QURE $BHVN
1 · Reply